ProCE Banner Activity

Personalized Therapy in the Era of Precision Medicine: Guidance on Histology-Agnostic Therapies for the Community Multidisciplinary Oncology Team


Downloadable slideset from a live workshop series on histology-agnostic biomarkers informing the care of solid tumors, including targeted therapies and immune checkpoint inhibitors.

Released: July 19, 2023



Razelle Kurzrock

Razelle Kurzrock, MD

Medical College of Wisconsin
Milwaukee, Wisconsin

Vivek Subbiah

Vivek Subbiah, MD

Chief, Early-Phase Drug Development
Sarah Cannon Research Institute
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., Elevation Oncology, Merck Sharp & Dohme Corp., and Merus NV.

Bayer HealthCare Pharmaceuticals Inc.

Elevation Oncology

Merck Sharp & Dohme Corp.

Merus NV